Lexpos News

Background Liverpool has historically had a limited community pharmacy offer for sexual and reproductive health, with only six pharmacies commissioned to provide oral Emergency Contraception (EC). A new commissioner with a strong interest in community pharmacy led a programme of extensive stakeholder engagement as part of the city’s wider sexual health strategy. Liverpool LPC’s Chief [...]

The post Case study: Developing a community pharmacy-led LARC implant service in Liverpool appeared first on Community Pharmacy England.

The Centre for Pharmacy Postgraduate Education (CPPE) has launched a new workshop designed to equip pharmacy technicians with the competence and confidence to safely supply or administer medicines under Patient Group Directions (PGDs). The two-hour face-to-face workshop, which will be held at various locations throughout England, develops the practical skills needed to apply PGD frameworks, [...]

The post New CPPE Empowering pharmacy technicians to provide services workshop appeared first on Community Pharmacy England.

Pharmacy owners taking part in the spring COVID-19 vaccination programme will require Federated Data Platform (FDP) access to order COVID-19 vaccines. Pharmacy owners can request FDP access here. A step-by-step guide is also available. If access issues occur, pharmacy owners should clear their browser cache, switch to Microsoft Edge or use an InPrivate/Incognito window and [...]

The post C-19 vac: Setting up FDP access appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the January 2026 concessionary price for Rosuvastatin 10mg tablets and Trimethoprim 100mg tablets: Drug Pack size Price concession Rosuvastatin 10mg tablets 28 £4.48 (previously £2.70) Trimethoprim 100mg tablets 28 £4.08 (previously £3.77) [...]

The post Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026 appeared first on Community Pharmacy England.

Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management and cardiovascular risk reduction. Patients reporting a sudden loss of vision (including partial loss) while [...]

The post MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) appeared first on Community Pharmacy England.